Theravance Biopharma, Inc. Basic Shares Outstanding (Weighted Average)
Theravance Biopharma, Inc. (TBPH) reported Basic Shares Outstanding (Weighted Average) of 51.67 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Theravance Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 51.67M shares, a 2.97% increase year-over-year.
- Theravance Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 51.28M shares, a 3.16% increase year-over-year.
- Theravance Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 50.86M shares, a 3.12% increase year-over-year.
- Theravance Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 50.52M shares, a 3.02% increase year-over-year.
- Theravance Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 50.32M shares, a 3.01% increase from fiscal 2024.
- Theravance Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 48.85M shares, a 11.67% decline from fiscal 2023.
- Theravance Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 55.30M shares, a 24.85% decline from fiscal 2022.
- Theravance Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 73.59M shares, a 5.95% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 51.67M shares 10-Q · filed 2026-08-11 | 51.47M shares 10-Q · filed 2026-08-11 | 51.27M shares derived: average of 3 quarters · filed 2026-08-11 | 51.08M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 51.28M shares 10-Q · filed 2026-05-07 | 51.07M shares derived: average of 2 quarters · filed 2026-05-07 | 50.89M shares derived: average of 3 quarters · filed 2026-05-07 | 50.71M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 50.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 50.69M shares derived: average of 2 quarters · filed 2026-03-23 | 50.52M shares derived: average of 3 quarters · filed 2026-08-11 | 50.32M shares 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | 50.52M shares 10-Q · filed 2025-11-12 | 50.35M shares derived: average of 2 quarters · filed 2026-08-11 | 50.14M shares 10-Q · filed 2025-11-12 | 49.93M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 50.18M shares 10-Q · filed 2026-08-11 | 49.94M shares 10-Q · filed 2026-08-11 | 49.73M shares derived: average of 3 quarters · filed 2026-08-11 | 49.56M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 49.71M shares 10-Q · filed 2026-05-07 | 49.51M shares derived: average of 2 quarters · filed 2026-05-07 | 49.35M shares derived: average of 3 quarters · filed 2026-05-07 | 49.20M shares derived: average of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | 49.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 49.18M shares derived: average of 2 quarters · filed 2026-03-23 | 49.03M shares derived: average of 3 quarters · filed 2026-03-23 | 48.85M shares 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | 49.04M shares 10-Q · filed 2025-11-12 | 48.89M shares derived: average of 2 quarters · filed 2025-11-12 | 48.69M shares 10-Q · filed 2025-11-12 | 48.85M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 48.75M shares 10-Q · filed 2025-08-13 | 48.52M shares 10-Q · filed 2025-08-13 | 48.79M shares derived: average of 3 quarters · filed 2025-08-13 | 49.69M shares derived: average of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | 48.28M shares 10-Q · filed 2025-05-12 | 48.82M shares derived: average of 2 quarters · filed 2025-05-12 | 50.00M shares derived: average of 3 quarters · filed 2025-05-12 | 51.67M shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 49.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | 50.86M shares derived: average of 2 quarters · filed 2025-03-07 | 52.80M shares derived: average of 3 quarters · filed 2025-03-07 | 55.30M shares 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | 52.36M shares 10-Q · filed 2024-11-14 | 54.52M shares derived: average of 2 quarters · filed 2024-11-14 | 57.29M shares 10-Q · filed 2024-11-14 | 59.83M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 56.68M shares 10-Q · filed 2024-08-08 | 59.79M shares 10-Q · filed 2024-08-08 | 62.32M shares derived: average of 3 quarters · filed 2024-08-08 | 65.62M shares derived: average of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | 62.93M shares 10-Q · filed 2024-05-15 | 65.13M shares derived: average of 2 quarters · filed 2024-05-15 | 68.59M shares derived: average of 3 quarters · filed 2024-05-15 | 70.51M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 67.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | 71.42M shares derived: average of 2 quarters · filed 2024-03-01 | 73.04M shares derived: average of 3 quarters · filed 2024-03-01 | 73.59M shares 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | 75.52M shares 10-Q · filed 2023-11-09 | 75.89M shares derived: average of 2 quarters · filed 2023-11-09 | 75.68M shares 10-Q · filed 2023-11-09 | 75.26M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 76.27M shares 10-Q · filed 2023-08-09 | 75.76M shares 10-Q · filed 2023-08-09 | 75.18M shares derived: average of 3 quarters · filed 2023-08-09 | 74.78M shares derived: average of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | 75.25M shares 10-Q · filed 2023-05-10 | 74.63M shares derived: average of 2 quarters · filed 2023-05-10 | 74.28M shares derived: average of 3 quarters · filed 2023-05-10 | 72.12M shares derived: average of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | 74.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 73.79M shares derived: average of 2 quarters · filed 2023-03-01 | 71.08M shares derived: average of 3 quarters · filed 2023-03-01 | 69.46M shares 10-K · filed 2023-03-01 | ||||
| 2021-09-30 | 73.57M shares 10-Q · filed 2022-11-09 | 69.62M shares derived: average of 2 quarters · filed 2022-11-09 | 67.94M shares 10-Q · filed 2022-11-09 | 66.87M shares derived: average of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | 65.67M shares 10-Q · filed 2022-08-08 | 65.08M shares 10-Q · filed 2022-08-08 | 65.20M shares 10-Q · filed 2021-08-05 | 64.63M shares derived: average of 3 quarters · filed 2023-03-01 | 64.30M shares derived: average of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | 64.49M shares 10-Q · filed 2022-05-06 | 64.72M shares 10-Q · filed 2021-05-06 | 64.11M shares derived: average of 2 quarters · filed 2023-03-01 | 63.84M shares derived: average of 3 quarters · filed 2023-03-01 | 63.70M shares derived: average of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | 63.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 63.52M shares derived: average of 2 quarters · filed 2023-03-01 | 63.44M shares derived: average of 3 quarters · filed 2023-03-01 | 62.34M shares 10-K · filed 2023-03-01 | 62.81M shares 10-K · filed 2021-02-26 | |||
| 2020-09-30 | 63.30M shares 10-Q · filed 2021-11-08 | 63.72M shares 10-Q · filed 2020-11-09 | 63.29M shares derived: average of 2 quarters · filed 2021-11-08 | 61.88M shares 10-Q · filed 2021-11-08 | 62.36M shares 10-Q · filed 2020-11-09 | 60.04M shares derived: average of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | 63.27M shares 10-Q · filed 2021-08-05 | 61.68M shares 10-Q · filed 2021-08-05 | 58.96M shares derived: average of 3 quarters · filed 2022-02-28 | 58.39M shares derived: average of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | 60.08M shares 10-Q · filed 2021-05-06 | 56.80M shares derived: average of 2 quarters · filed 2022-02-28 | 56.76M shares derived: average of 3 quarters · filed 2022-02-28 | 56.67M shares derived: average of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | 53.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 55.10M shares derived: average of 2 quarters · filed 2022-02-28 | 55.54M shares derived: average of 3 quarters · filed 2022-02-28 | 55.61M shares 10-K · filed 2022-02-28 | 56.45M shares 10-K · filed 2020-02-27 | |||
| 2019-09-30 | 56.69M shares 10-Q · filed 2020-11-09 | 56.55M shares derived: average of 2 quarters · filed 2020-11-09 | 56.31M shares 10-Q · filed 2020-11-09 | 56.11M shares derived: average of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | 56.41M shares 10-Q · filed 2020-08-10 | 56.11M shares 10-Q · filed 2020-08-10 | 55.92M shares derived: average of 3 quarters · filed 2021-02-26 | 55.75M shares derived: average of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | 55.82M shares 10-Q · filed 2020-05-08 | 55.68M shares derived: average of 2 quarters · filed 2021-02-26 | 55.53M shares derived: average of 3 quarters · filed 2021-02-26 | 55.39M shares derived: average of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | 55.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 55.39M shares derived: average of 2 quarters · filed 2021-02-26 | 55.24M shares derived: average of 3 quarters · filed 2021-02-26 | 55.08M shares 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | 55.23M shares 10-Q · filed 2019-11-08 | 55.09M shares derived: average of 2 quarters · filed 2019-11-08 | 54.92M shares 10-Q · filed 2019-11-08 | |||||
| 2018-06-30 | 54.96M shares 10-Q · filed 2019-08-05 | 54.76M shares 10-Q · filed 2019-08-05 | ||||||
| 2017-12-31 | 53.70M shares 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |